๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Metrifonate: A Cholinesterase Inhibitor for Alzheimer's Disease Therapy

โœ Scribed by Lon S. Schneider; Ezio Giacobini

Book ID
109105454
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
130 KB
Volume
5
Category
Article
ISSN
1080-563X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Initiating and monitoring cholinesterase
Initiating and monitoring cholinesterase inhibitor treatment for Alzheimer's disease
โœ Gregory R. J. Swanwick; Brian A. Lawlor ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB ๐Ÿ‘ 2 views

The availability of acetylcholinesterase inhibitors for the treatment of Alzheimer's disease raises a number of clinical and ethical questions. Many of the guidelines published in an attempt to tackle these questions lack either clinical or scientiยฎc validity. Against this background a model is prop

Switching cholinesterase inhibitor thera
Switching cholinesterase inhibitor therapy in Alzheimer's diseaseโ€”donepezil to rivastigmine, is it worth it?
โœ Roger Bullock; Claire Connolly ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 34 KB ๐Ÿ‘ 1 views

Switching from donepezil to rivastigmine was beneยฎcial in cognitive and global terms in 55.0% of the patients with Alzheimer's disease studied. \* Side-effects on donepezil and rivastigmine were independent of one another. \* It may be possible to extend the positive effects that cholinesterase inhi